About
Gateway for Cancer Research is a Chicago-based 501(c)(3) nonprofit that funds early-phase (Phase I and Phase II) human clinical cancer trials at leading research institutions around the world. Founded in 1991, Gateway's stated aim is to shape a world in which a cancer diagnosis is no longer feared by accelerating practice-changing discoveries in cancer care.
Mission
Gateway funds innovative Phase I and Phase II clinical trials for all cancer types, with the goal of shaping a world in which a cancer diagnosis is no longer feared. Chairman Richard J Stephenson describes the organization's work as funding innovative clinical research centered on one objective: to end cancer as we know it, with a focus on producing real, tangible results through philanthropic support.
What they do
- Funds early-phase (Phase I and Phase II) human clinical cancer trials across all cancer types
- Supports trials at leading research institutions worldwide
- Commits that 100 percent of every dollar it receives directly funds Phase I and Phase II cancer clinical trials
History
Gateway for Cancer Research was founded in 1991. Richard J Stephenson chairs the organization's board.
Scale and impact
According to the organization, since 1991 Gateway has funded more than 254 clinical trials worldwide and more than 126 million dollars in cancer research, and its funded trials have impacted over 10,000 patients. Gateway states that the cost of a Gateway-funded trial works out to 34 dollars per patient per day. The organization holds a GuideStar Platinum Seal of Transparency.
Financials
Per its IRS filings summarized on ProPublica Nonprofit Explorer, Gateway for Cancer Research reported total revenue of 9,653,289 dollars and total expenses of 11,190,912 dollars for the fiscal year ending June 2025, with net assets of 13,713,650 dollars. For the fiscal year ending June 2024, it reported revenue of 9,383,526 dollars and expenses of 8,628,310 dollars. The bulk of its revenue comes from contributions. The organization's federal tax exemption was issued in June 1992 (EIN 73-1386920).
Governance
Gateway is governed by a Board of Directors chaired by Richard J Stephenson, supported by a Research and Grants Committee that oversees the selection of funded trials. Per the organization's IRS filings summarized on ProPublica, Natalie Stewart served as president through May 2025, with Michael Jessup then serving as interim CEO.